Wockhardt's arm gets approval for Oxycodone Hydrochloride Oral Solution

19 Jun 2015 Evaluate

Wockhardt Bio AG, a subsidiary of Wockhardt, has reportedly received approval from US FDA for its abbreviated new drug application (ANDA) for Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL. The Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL, is bioequivalent and, therefore, therapeutically equivalent to the reference listed drug product (RLD), Oxycodone Hydrocodone Oral Solution, USP 5 mg/5 mL, of VistaPharm, Inc.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1357.80 18.05 (1.35%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×